Stoke Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC STOK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

57,212

Value ($000)

1,816

Weight

0.0%

2023 Q1 - 2025 Q4 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,816	0.0%	57,212	12/31/2025
2025 Q3	11/14/2025	1,783	0.0%	75,858	9/30/2025
2025 Q2	8/14/2025	1,217	0.0%	107,240	6/30/2025
2025 Q1	5/19/2025	551	0.0%	82,802	3/31/2025
2024 Q4	2/14/2025	1,053	0.0%	95,505	12/31/2024
2024 Q3	11/14/2024	525	0.0%	42,692	9/30/2024
2024 Q2	8/14/2024	775	0.0%	57,399	6/30/2024
2023 Q3	11/13/2023	45	0.0%	11,398	9/30/2023
2023 Q2	8/11/2023	95	0.0%	11,398	6/30/2023
2023 Q1	5/15/2023	95	0.0%	11,398	3/31/2023